Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-30

FDA Approved: FYCOMPA — Supplemental Application (Eisai Inc.)

View source ↗

Summary

The FDA approved Eisai's supplemental application for FYCOMPA (perampanel), marking an approval of changes to the product's labeling related to a supplemental r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fycompa (perampanel)

Snippet

SUPPL AP for FYCOMPA (PERAMPANEL)